Susan L. Litterst
Associate Director, Contracts Specialist
Associate Director, Contracts Specialist
Areas of Focus
Overview
Susan Litterst has been helping pharmaceutical and biotech companies meet their various contacting needs for more than 20 years, including by drafting and negotiating agreements and managing the contracting process for large, multinational clinical studies.
Career & Education
- U.S. Securities and Exchange Commission
Student Honors Program Extern, Enforcement Division - U.S. District Court for the Southern District of New York
Judicial Internship - U.S. District Court, District of Massachusetts
Judicial Internship
- U.S. Securities and Exchange Commission
- Legal Advisor, Warner-Lambert Company (now Pfizer)
-
- Supported the Medical/Scientific Affairs, Research and Development and Healthcare Management groups
- Responsible for pre-clinical and clinical agreements in support of the company’s clinical and drug development programs, such as sponsored research and material transfer agreements, clinical trial, lab services, consulting, CRO and ancillary vendor agreements
- Provided project management assistance to various business units of the company and created portfolios of template documents
-
- Dow Jones & Company
-
- Reviewed and negotiated contracts relative to the company’s financial and newswire businesses
-
- Legal Advisor, Warner-Lambert Company (now Pfizer)
- Ramapo College of New Jersey, B.A., cum laude
- Adelphi University, Paralegal Certificate
Representative Matters
- Drafted and negotiated agreements and managed contracting process for single-center and multi-center, U.S. and ex-U.S. clinical trials (Phase 1 through Phase 3), including a Phase 3 clinical trial involving approximately 520 subjects across sites located in the U.S., Europe, and APAC.
- Drafted and negotiated agreements and managed contracting process for several large clinical trials of a US based biotechnology company’s oncology therapies, including:
-
- Pivotal Phase 3 trial involving over 600 subjects in over 200 sites in the U.S., Europe, APAC and South America.
- Multiple Phase 1 and Phase 2 trials in the U.S., Europe and APAC.
-
- Negotiated complex services agreements for pre-clinical and clinical studies on behalf of various clients, including multi-million-dollar master services agreements with large, multinational contract research organizations for multinational, pivotal clinical trials